Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Back
Share this video  

BTOG 2018 | BTOG 2018 speaker highlights

Alastair Greystoke, David Baldwin, Dean Fennell, Jeanette Dickson, Kenneth O'Byrne and Sanjay Agrawal • 24 Jan 2018
BTOG 2018
Lung Cancer Non-Small Cell Lung Cancer Small Cell Lung Cancer

A record number of delegates attended the British Thoracic Oncology Group (BTOG) Annual Conference 2018, held in Dublin, Ireland. Although exciting advancements in research and practice were presented, but the attendees emphasize that this is not the only reason that they attend the BTOG conference every year. For an expert insight into the meeting, hear from the presenters themselves. See you at BTOG 2019!

More from Alastair Greystoke

6:20
Solid tumor genomic testing in the UK: challenges and solutions
Alastair Greystoke • 28 Apr 2023
1:51
NHS England: a pilot ctDNA study to track patient responses to novel genomic targets
Alastair Greystoke • 27 Apr 2023
5:59
Deciphering an NGS report in lung cancer
Alastair Greystoke • 24 Jan 2022
3:34
Strategies to improve biomarker testing in the UK
Alastair Greystoke • 24 Jan 2022

More from David Baldwin

3:36
Facilitating the decision-making process for patients during lung cancer screening
David Baldwin • 29 Aug 2023
1:33
Strategies for ensuring the cost-effectiveness of lung cancer screening in the UK
David Baldwin • 29 Aug 2023
1:32
Advancements in the UK’s national screening programme for lung cancer
David Baldwin • 29 Aug 2023
1:26
Highlights from WCLC 2022: CT screening
David Baldwin • 7 Aug 2022

More from Dean Fennell

1:14
ATOMIC: treating mesothelioma with an arginine-degrading enzyme and combination chemotherapy
Dean Fennell • 27 Apr 2023
3:34
Role of immunotherapy in the management of mesothelioma
Dean Fennell • 31 Mar 2023
6:43
Personalized medicine in mesothelioma
Dean Fennell • 31 Mar 2023
1:54
Abemaciclib in patients with p16ink4a negative, relapsed mesothelioma
Dean Fennell • 21 May 2021

More from Jeanette Dickson

3:14
The key unanswered question in lung cancer?
Alastair Greystoke et al. • 25 Jan 2018
1:41
The current landscape of radiotherapy services in the UK
Jeanette Dickson • 26 Jan 2018
0:43
Lung cancer care: the technology is there, but what else is needed?
Jeanette Dickson • 26 Jan 2018
0:32
The importance of BTOG for multiprofessional communication
Jeanette Dickson • 26 Jan 2018

More from Kenneth O'Byrne

5:55
Checkpoint inhibitor resistance in lung cancer
Kenneth O'Byrne • 30 Jan 2020
3:03
The tumor microenvironment: lung cancer
Kenneth O'Byrne • 30 Jan 2020
2:33
Concurrent immunotherapy in SCLC
Kenneth O'Byrne • 31 Jan 2020
2:28
Painting the lung cancer cell picture
Kenneth O'Byrne • 30 Jan 2020

More from Sanjay Agrawal

2:02
Quitting: is vaping effective for patients?
Sanjay Agrawal • 30 Jan 2020
2:21
The vaping-related lung injury epidemic
Sanjay Agrawal • 30 Jan 2020
3:14
The key unanswered question in lung cancer?
Alastair Greystoke et al. • 25 Jan 2018
0:37
The recording and referral of smokers in the UK: an area for improvement
Sanjay Agrawal • 25 Jan 2018

Related Videos

7:37
What is the optimal follow-up for lung cancer long term survivors?
Robert Rintoul • 19 Apr 2024
2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
1:47
Assessing follow-up strategies in post-surgical lung cancer: insights from a Phase III trial
Robert Rintoul • 19 Apr 2024
0:45
Assessing treatment options for lung cancer with interstitial lung disease
Matthew Hatton • 18 Apr 2024
The content of VJOncology is intended for healthcare professionals